World Journal of Clinical Cases-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1206855, encodeId=b1701206855d2, content=上周周末汇版面费，今天发现银行那边收取15美元的手续费，我是该后期补交这个手续费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91395727558, createdName=ms8000001964189397, createdTime=Tue Mar 29 11:01:50 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147516, encodeId=c332214e51636, content=期刊名称：World Journal of Clinical Cases 影响因子：1.1 JCR分区：Q4 中科院分区：医学4区 小类：医学：内科4区 OPEN ACCESS：不清楚 出版周期：暂无数据 是否综述：否 预警等级：2023年中科院中风险预警（2021年中风险），多地黑名单预警（2023江苏省肿瘤医院中危预警、2023年度北京301医院预警、长江大学中风险预警、2022复旦大学附属华山医院不鼓励投稿预警期刊、上海市第一人民医院预警） 无视预警的单位果断投，每年收几千篇文章，属于比较好中的，速度也快，就是投稿过程比较繁琐，本人3月投的文章，6月底接收，不影响明年毕业~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e9c968577, createdName=lunasanger, createdTime=Tue Jul 11 19:16:22 CST 2023, time=2023-07-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2145331, encodeId=18f421453310f, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：病例报道;肿瘤 经验分享：竟然影响因子也有1.1分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:40:19 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1059261, encodeId=546f10592612b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：胃肠 经验分享：6月投，7月大修，9月修回。然后一定要让签署electric copyright,可惜这个electric copyright只发给了第一作者，没有发给通讯作者，然后通讯作者一直接收不到，而第一作者转发给通讯作者的电子版权协议，因为已经点击过，就没办法再点击，然后就一直耽误着，出版社说发了几次了，但始终没有接收到是怎么回事？通讯作者是hotmail的邮箱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33f45280010, createdName=1483f2a9m06(暂无昵称), createdTime=Sun Oct 10 21:39:44 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184498, encodeId=2504118449814, content=想问一下这个copyright license agreement 要五天之内提交但是并没有提交按钮还是说所有作者只要点击了accept就可以了然后和修改的文章14天之内提交上就好呀谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3085595427, createdName=ms2000000810824338, createdTime=Sat Jan 15 09:01:15 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107181, encodeId=0d7c210e181e0, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8022567422, createdName=12576f0em36暂无昵称, createdTime=Fri Dec 23 18:31:42 CST 2022, time=2022-12-23, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112349, encodeId=ea04211234942, content=我就想知道有没有被拒稿的😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Tue Jan 31 10:11:43 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2111130, encodeId=f84a211113052, content=问下各位，这个杂志让把图片编辑成PPT，可是在哪里提交呀，最后那里也没有可以提交PPT的选项呀，还是点了submit以后再提交？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14165129858, createdName=146534d9m02暂无昵称, createdTime=Sun Jan 22 11:19:47 CST 2023, time=2023-01-22, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2111261, encodeId=2d0721112616b, content=感觉今年还是预警不想发了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Mon Jan 23 23:30:07 CST 2023, time=2023-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2109480, encodeId=7433210948024, content=请问一下大家，这个copyright license agreement 所有作者都点了accept了，但邮件里说要五天之内提交，大家在哪里提交的啊？还是和修改的文章14天之内提交上就好了呀？谢谢大家！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Mon Jan 09 10:02:52 CST 2023, time=2023-01-09, status=1, ipAttribution=浙江省)]

2022-03-29 ms8000001964189397

上周周末汇版面费，今天发现银行那边收取15美元的手续费，我是该后期补交这个手续费么？

63 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1206855, encodeId=b1701206855d2, content=上周周末汇版面费，今天发现银行那边收取15美元的手续费，我是该后期补交这个手续费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91395727558, createdName=ms8000001964189397, createdTime=Tue Mar 29 11:01:50 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147516, encodeId=c332214e51636, content=期刊名称：World Journal of Clinical Cases 影响因子：1.1 JCR分区：Q4 中科院分区：医学4区 小类：医学：内科4区 OPEN ACCESS：不清楚 出版周期：暂无数据 是否综述：否 预警等级：2023年中科院中风险预警（2021年中风险），多地黑名单预警（2023江苏省肿瘤医院中危预警、2023年度北京301医院预警、长江大学中风险预警、2022复旦大学附属华山医院不鼓励投稿预警期刊、上海市第一人民医院预警） 无视预警的单位果断投，每年收几千篇文章，属于比较好中的，速度也快，就是投稿过程比较繁琐，本人3月投的文章，6月底接收，不影响明年毕业~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e9c968577, createdName=lunasanger, createdTime=Tue Jul 11 19:16:22 CST 2023, time=2023-07-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2145331, encodeId=18f421453310f, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：病例报道;肿瘤 经验分享：竟然影响因子也有1.1分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:40:19 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1059261, encodeId=546f10592612b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：胃肠 经验分享：6月投，7月大修，9月修回。然后一定要让签署electric copyright,可惜这个electric copyright只发给了第一作者，没有发给通讯作者，然后通讯作者一直接收不到，而第一作者转发给通讯作者的电子版权协议，因为已经点击过，就没办法再点击，然后就一直耽误着，出版社说发了几次了，但始终没有接收到是怎么回事？通讯作者是hotmail的邮箱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33f45280010, createdName=1483f2a9m06(暂无昵称), createdTime=Sun Oct 10 21:39:44 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184498, encodeId=2504118449814, content=想问一下这个copyright license agreement 要五天之内提交但是并没有提交按钮还是说所有作者只要点击了accept就可以了然后和修改的文章14天之内提交上就好呀谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3085595427, createdName=ms2000000810824338, createdTime=Sat Jan 15 09:01:15 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107181, encodeId=0d7c210e181e0, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8022567422, createdName=12576f0em36暂无昵称, createdTime=Fri Dec 23 18:31:42 CST 2022, time=2022-12-23, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112349, encodeId=ea04211234942, content=我就想知道有没有被拒稿的😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Tue Jan 31 10:11:43 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2111130, encodeId=f84a211113052, content=问下各位，这个杂志让把图片编辑成PPT，可是在哪里提交呀，最后那里也没有可以提交PPT的选项呀，还是点了submit以后再提交？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14165129858, createdName=146534d9m02暂无昵称, createdTime=Sun Jan 22 11:19:47 CST 2023, time=2023-01-22, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2111261, encodeId=2d0721112616b, content=感觉今年还是预警不想发了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Mon Jan 23 23:30:07 CST 2023, time=2023-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2109480, encodeId=7433210948024, content=请问一下大家，这个copyright license agreement 所有作者都点了accept了，但邮件里说要五天之内提交，大家在哪里提交的啊？还是和修改的文章14天之内提交上就好了呀？谢谢大家！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Mon Jan 09 10:02:52 CST 2023, time=2023-01-09, status=1, ipAttribution=浙江省)]

2023-07-11 lunasanger 来自上海

期刊名称：World Journal of Clinical Cases
影响因子：1.1
JCR分区：Q4
中科院分区：医学4区
小类：医学：内科4区
OPEN ACCESS：不清楚
出版周期：暂无数据
是否综述：否
预警等级：2023年中科院中风险预警（2021年中风险），多地黑名单预警（2023江苏省肿瘤医院中危预警、2023年度北京301医院预警、长江大学中风险预警、2022复旦大学附属华山医院不鼓励投稿预警期刊、上海市第一人民医院预警）
无视预警的单位果断投，每年收几千篇文章，属于比较好中的，速度也快，就是投稿过程比较繁琐，本人3月投的文章，6月底接收，不影响明年毕业~

61 0

[GetPortalCommentsPageByObjectIdResponse(id=1206855, encodeId=b1701206855d2, content=上周周末汇版面费，今天发现银行那边收取15美元的手续费，我是该后期补交这个手续费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91395727558, createdName=ms8000001964189397, createdTime=Tue Mar 29 11:01:50 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147516, encodeId=c332214e51636, content=期刊名称：World Journal of Clinical Cases 影响因子：1.1 JCR分区：Q4 中科院分区：医学4区 小类：医学：内科4区 OPEN ACCESS：不清楚 出版周期：暂无数据 是否综述：否 预警等级：2023年中科院中风险预警（2021年中风险），多地黑名单预警（2023江苏省肿瘤医院中危预警、2023年度北京301医院预警、长江大学中风险预警、2022复旦大学附属华山医院不鼓励投稿预警期刊、上海市第一人民医院预警） 无视预警的单位果断投，每年收几千篇文章，属于比较好中的，速度也快，就是投稿过程比较繁琐，本人3月投的文章，6月底接收，不影响明年毕业~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e9c968577, createdName=lunasanger, createdTime=Tue Jul 11 19:16:22 CST 2023, time=2023-07-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2145331, encodeId=18f421453310f, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：病例报道;肿瘤 经验分享：竟然影响因子也有1.1分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:40:19 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1059261, encodeId=546f10592612b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：胃肠 经验分享：6月投，7月大修，9月修回。然后一定要让签署electric copyright,可惜这个electric copyright只发给了第一作者，没有发给通讯作者，然后通讯作者一直接收不到，而第一作者转发给通讯作者的电子版权协议，因为已经点击过，就没办法再点击，然后就一直耽误着，出版社说发了几次了，但始终没有接收到是怎么回事？通讯作者是hotmail的邮箱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33f45280010, createdName=1483f2a9m06(暂无昵称), createdTime=Sun Oct 10 21:39:44 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184498, encodeId=2504118449814, content=想问一下这个copyright license agreement 要五天之内提交但是并没有提交按钮还是说所有作者只要点击了accept就可以了然后和修改的文章14天之内提交上就好呀谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3085595427, createdName=ms2000000810824338, createdTime=Sat Jan 15 09:01:15 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107181, encodeId=0d7c210e181e0, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8022567422, createdName=12576f0em36暂无昵称, createdTime=Fri Dec 23 18:31:42 CST 2022, time=2022-12-23, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112349, encodeId=ea04211234942, content=我就想知道有没有被拒稿的😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Tue Jan 31 10:11:43 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2111130, encodeId=f84a211113052, content=问下各位，这个杂志让把图片编辑成PPT，可是在哪里提交呀，最后那里也没有可以提交PPT的选项呀，还是点了submit以后再提交？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14165129858, createdName=146534d9m02暂无昵称, createdTime=Sun Jan 22 11:19:47 CST 2023, time=2023-01-22, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2111261, encodeId=2d0721112616b, content=感觉今年还是预警不想发了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Mon Jan 23 23:30:07 CST 2023, time=2023-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2109480, encodeId=7433210948024, content=请问一下大家，这个copyright license agreement 所有作者都点了accept了，但邮件里说要五天之内提交，大家在哪里提交的啊？还是和修改的文章14天之内提交上就好了呀？谢谢大家！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Mon Jan 09 10:02:52 CST 2023, time=2023-01-09, status=1, ipAttribution=浙江省)]

2023-06-29 侠胆医心来自香港

审稿速度:2.0 | 投稿命中率:95.0
偏重的研究方向：病例报道;肿瘤
经验分享：竟然影响因子也有1.1分

46 0

[GetPortalCommentsPageByObjectIdResponse(id=1206855, encodeId=b1701206855d2, content=上周周末汇版面费，今天发现银行那边收取15美元的手续费，我是该后期补交这个手续费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91395727558, createdName=ms8000001964189397, createdTime=Tue Mar 29 11:01:50 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147516, encodeId=c332214e51636, content=期刊名称：World Journal of Clinical Cases 影响因子：1.1 JCR分区：Q4 中科院分区：医学4区 小类：医学：内科4区 OPEN ACCESS：不清楚 出版周期：暂无数据 是否综述：否 预警等级：2023年中科院中风险预警（2021年中风险），多地黑名单预警（2023江苏省肿瘤医院中危预警、2023年度北京301医院预警、长江大学中风险预警、2022复旦大学附属华山医院不鼓励投稿预警期刊、上海市第一人民医院预警） 无视预警的单位果断投，每年收几千篇文章，属于比较好中的，速度也快，就是投稿过程比较繁琐，本人3月投的文章，6月底接收，不影响明年毕业~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e9c968577, createdName=lunasanger, createdTime=Tue Jul 11 19:16:22 CST 2023, time=2023-07-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2145331, encodeId=18f421453310f, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：病例报道;肿瘤 经验分享：竟然影响因子也有1.1分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:40:19 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1059261, encodeId=546f10592612b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：胃肠 经验分享：6月投，7月大修，9月修回。然后一定要让签署electric copyright,可惜这个electric copyright只发给了第一作者，没有发给通讯作者，然后通讯作者一直接收不到，而第一作者转发给通讯作者的电子版权协议，因为已经点击过，就没办法再点击，然后就一直耽误着，出版社说发了几次了，但始终没有接收到是怎么回事？通讯作者是hotmail的邮箱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33f45280010, createdName=1483f2a9m06(暂无昵称), createdTime=Sun Oct 10 21:39:44 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184498, encodeId=2504118449814, content=想问一下这个copyright license agreement 要五天之内提交但是并没有提交按钮还是说所有作者只要点击了accept就可以了然后和修改的文章14天之内提交上就好呀谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3085595427, createdName=ms2000000810824338, createdTime=Sat Jan 15 09:01:15 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107181, encodeId=0d7c210e181e0, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8022567422, createdName=12576f0em36暂无昵称, createdTime=Fri Dec 23 18:31:42 CST 2022, time=2022-12-23, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112349, encodeId=ea04211234942, content=我就想知道有没有被拒稿的😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Tue Jan 31 10:11:43 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2111130, encodeId=f84a211113052, content=问下各位，这个杂志让把图片编辑成PPT，可是在哪里提交呀，最后那里也没有可以提交PPT的选项呀，还是点了submit以后再提交？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14165129858, createdName=146534d9m02暂无昵称, createdTime=Sun Jan 22 11:19:47 CST 2023, time=2023-01-22, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2111261, encodeId=2d0721112616b, content=感觉今年还是预警不想发了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Mon Jan 23 23:30:07 CST 2023, time=2023-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2109480, encodeId=7433210948024, content=请问一下大家，这个copyright license agreement 所有作者都点了accept了，但邮件里说要五天之内提交，大家在哪里提交的啊？还是和修改的文章14天之内提交上就好了呀？谢谢大家！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Mon Jan 09 10:02:52 CST 2023, time=2023-01-09, status=1, ipAttribution=浙江省)]

2021-10-10 1483f2a9m06(暂无昵称)

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：胃肠
经验分享：6月投，7月大修，9月修回。然后一定要让签署electric copyright,可惜这个electric copyright只发给了第一作者，没有发给通讯作者，然后通讯作者一直接收不到，而第一作者转发给通讯作者的电子版权协议，因为已经点击过，就没办法再点击，然后就一直耽误着，出版社说发了几次了，但始终没有接收到是怎么回事？通讯作者是hotmail的邮箱。

85 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=1206855, encodeId=b1701206855d2, content=上周周末汇版面费，今天发现银行那边收取15美元的手续费，我是该后期补交这个手续费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91395727558, createdName=ms8000001964189397, createdTime=Tue Mar 29 11:01:50 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147516, encodeId=c332214e51636, content=期刊名称：World Journal of Clinical Cases 影响因子：1.1 JCR分区：Q4 中科院分区：医学4区 小类：医学：内科4区 OPEN ACCESS：不清楚 出版周期：暂无数据 是否综述：否 预警等级：2023年中科院中风险预警（2021年中风险），多地黑名单预警（2023江苏省肿瘤医院中危预警、2023年度北京301医院预警、长江大学中风险预警、2022复旦大学附属华山医院不鼓励投稿预警期刊、上海市第一人民医院预警） 无视预警的单位果断投，每年收几千篇文章，属于比较好中的，速度也快，就是投稿过程比较繁琐，本人3月投的文章，6月底接收，不影响明年毕业~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e9c968577, createdName=lunasanger, createdTime=Tue Jul 11 19:16:22 CST 2023, time=2023-07-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2145331, encodeId=18f421453310f, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：病例报道;肿瘤 经验分享：竟然影响因子也有1.1分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:40:19 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1059261, encodeId=546f10592612b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：胃肠 经验分享：6月投，7月大修，9月修回。然后一定要让签署electric copyright,可惜这个electric copyright只发给了第一作者，没有发给通讯作者，然后通讯作者一直接收不到，而第一作者转发给通讯作者的电子版权协议，因为已经点击过，就没办法再点击，然后就一直耽误着，出版社说发了几次了，但始终没有接收到是怎么回事？通讯作者是hotmail的邮箱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33f45280010, createdName=1483f2a9m06(暂无昵称), createdTime=Sun Oct 10 21:39:44 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184498, encodeId=2504118449814, content=想问一下这个copyright license agreement 要五天之内提交但是并没有提交按钮还是说所有作者只要点击了accept就可以了然后和修改的文章14天之内提交上就好呀谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3085595427, createdName=ms2000000810824338, createdTime=Sat Jan 15 09:01:15 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107181, encodeId=0d7c210e181e0, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8022567422, createdName=12576f0em36暂无昵称, createdTime=Fri Dec 23 18:31:42 CST 2022, time=2022-12-23, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112349, encodeId=ea04211234942, content=我就想知道有没有被拒稿的😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Tue Jan 31 10:11:43 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2111130, encodeId=f84a211113052, content=问下各位，这个杂志让把图片编辑成PPT，可是在哪里提交呀，最后那里也没有可以提交PPT的选项呀，还是点了submit以后再提交？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14165129858, createdName=146534d9m02暂无昵称, createdTime=Sun Jan 22 11:19:47 CST 2023, time=2023-01-22, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2111261, encodeId=2d0721112616b, content=感觉今年还是预警不想发了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Mon Jan 23 23:30:07 CST 2023, time=2023-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2109480, encodeId=7433210948024, content=请问一下大家，这个copyright license agreement 所有作者都点了accept了，但邮件里说要五天之内提交，大家在哪里提交的啊？还是和修改的文章14天之内提交上就好了呀？谢谢大家！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Mon Jan 09 10:02:52 CST 2023, time=2023-01-09, status=1, ipAttribution=浙江省)]

2022-01-15 ms2000000810824338

想问一下这个copyright license agreement 要五天之内提交但是并没有提交按钮还是说所有作者只要点击了accept就可以了然后和修改的文章14天之内提交上就好呀谢谢大家

1 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1206855, encodeId=b1701206855d2, content=上周周末汇版面费，今天发现银行那边收取15美元的手续费，我是该后期补交这个手续费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91395727558, createdName=ms8000001964189397, createdTime=Tue Mar 29 11:01:50 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147516, encodeId=c332214e51636, content=期刊名称：World Journal of Clinical Cases 影响因子：1.1 JCR分区：Q4 中科院分区：医学4区 小类：医学：内科4区 OPEN ACCESS：不清楚 出版周期：暂无数据 是否综述：否 预警等级：2023年中科院中风险预警（2021年中风险），多地黑名单预警（2023江苏省肿瘤医院中危预警、2023年度北京301医院预警、长江大学中风险预警、2022复旦大学附属华山医院不鼓励投稿预警期刊、上海市第一人民医院预警） 无视预警的单位果断投，每年收几千篇文章，属于比较好中的，速度也快，就是投稿过程比较繁琐，本人3月投的文章，6月底接收，不影响明年毕业~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e9c968577, createdName=lunasanger, createdTime=Tue Jul 11 19:16:22 CST 2023, time=2023-07-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2145331, encodeId=18f421453310f, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：病例报道;肿瘤 经验分享：竟然影响因子也有1.1分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:40:19 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1059261, encodeId=546f10592612b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：胃肠 经验分享：6月投，7月大修，9月修回。然后一定要让签署electric copyright,可惜这个electric copyright只发给了第一作者，没有发给通讯作者，然后通讯作者一直接收不到，而第一作者转发给通讯作者的电子版权协议，因为已经点击过，就没办法再点击，然后就一直耽误着，出版社说发了几次了，但始终没有接收到是怎么回事？通讯作者是hotmail的邮箱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33f45280010, createdName=1483f2a9m06(暂无昵称), createdTime=Sun Oct 10 21:39:44 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184498, encodeId=2504118449814, content=想问一下这个copyright license agreement 要五天之内提交但是并没有提交按钮还是说所有作者只要点击了accept就可以了然后和修改的文章14天之内提交上就好呀谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3085595427, createdName=ms2000000810824338, createdTime=Sat Jan 15 09:01:15 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107181, encodeId=0d7c210e181e0, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8022567422, createdName=12576f0em36暂无昵称, createdTime=Fri Dec 23 18:31:42 CST 2022, time=2022-12-23, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112349, encodeId=ea04211234942, content=我就想知道有没有被拒稿的😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Tue Jan 31 10:11:43 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2111130, encodeId=f84a211113052, content=问下各位，这个杂志让把图片编辑成PPT，可是在哪里提交呀，最后那里也没有可以提交PPT的选项呀，还是点了submit以后再提交？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14165129858, createdName=146534d9m02暂无昵称, createdTime=Sun Jan 22 11:19:47 CST 2023, time=2023-01-22, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2111261, encodeId=2d0721112616b, content=感觉今年还是预警不想发了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Mon Jan 23 23:30:07 CST 2023, time=2023-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2109480, encodeId=7433210948024, content=请问一下大家，这个copyright license agreement 所有作者都点了accept了，但邮件里说要五天之内提交，大家在哪里提交的啊？还是和修改的文章14天之内提交上就好了呀？谢谢大家！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Mon Jan 09 10:02:52 CST 2023, time=2023-01-09, status=1, ipAttribution=浙江省)]

2022-12-23 12576f0em36暂无昵称来自四川省

审稿速度:2.0 | 投稿命中率:95.0
偏重的研究方向：肿瘤
经验分享：已接收

63 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1206855, encodeId=b1701206855d2, content=上周周末汇版面费，今天发现银行那边收取15美元的手续费，我是该后期补交这个手续费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91395727558, createdName=ms8000001964189397, createdTime=Tue Mar 29 11:01:50 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147516, encodeId=c332214e51636, content=期刊名称：World Journal of Clinical Cases 影响因子：1.1 JCR分区：Q4 中科院分区：医学4区 小类：医学：内科4区 OPEN ACCESS：不清楚 出版周期：暂无数据 是否综述：否 预警等级：2023年中科院中风险预警（2021年中风险），多地黑名单预警（2023江苏省肿瘤医院中危预警、2023年度北京301医院预警、长江大学中风险预警、2022复旦大学附属华山医院不鼓励投稿预警期刊、上海市第一人民医院预警） 无视预警的单位果断投，每年收几千篇文章，属于比较好中的，速度也快，就是投稿过程比较繁琐，本人3月投的文章，6月底接收，不影响明年毕业~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e9c968577, createdName=lunasanger, createdTime=Tue Jul 11 19:16:22 CST 2023, time=2023-07-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2145331, encodeId=18f421453310f, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：病例报道;肿瘤 经验分享：竟然影响因子也有1.1分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:40:19 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1059261, encodeId=546f10592612b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：胃肠 经验分享：6月投，7月大修，9月修回。然后一定要让签署electric copyright,可惜这个electric copyright只发给了第一作者，没有发给通讯作者，然后通讯作者一直接收不到，而第一作者转发给通讯作者的电子版权协议，因为已经点击过，就没办法再点击，然后就一直耽误着，出版社说发了几次了，但始终没有接收到是怎么回事？通讯作者是hotmail的邮箱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33f45280010, createdName=1483f2a9m06(暂无昵称), createdTime=Sun Oct 10 21:39:44 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184498, encodeId=2504118449814, content=想问一下这个copyright license agreement 要五天之内提交但是并没有提交按钮还是说所有作者只要点击了accept就可以了然后和修改的文章14天之内提交上就好呀谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3085595427, createdName=ms2000000810824338, createdTime=Sat Jan 15 09:01:15 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107181, encodeId=0d7c210e181e0, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8022567422, createdName=12576f0em36暂无昵称, createdTime=Fri Dec 23 18:31:42 CST 2022, time=2022-12-23, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112349, encodeId=ea04211234942, content=我就想知道有没有被拒稿的😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Tue Jan 31 10:11:43 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2111130, encodeId=f84a211113052, content=问下各位，这个杂志让把图片编辑成PPT，可是在哪里提交呀，最后那里也没有可以提交PPT的选项呀，还是点了submit以后再提交？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14165129858, createdName=146534d9m02暂无昵称, createdTime=Sun Jan 22 11:19:47 CST 2023, time=2023-01-22, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2111261, encodeId=2d0721112616b, content=感觉今年还是预警不想发了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Mon Jan 23 23:30:07 CST 2023, time=2023-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2109480, encodeId=7433210948024, content=请问一下大家，这个copyright license agreement 所有作者都点了accept了，但邮件里说要五天之内提交，大家在哪里提交的啊？还是和修改的文章14天之内提交上就好了呀？谢谢大家！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Mon Jan 09 10:02:52 CST 2023, time=2023-01-09, status=1, ipAttribution=浙江省)]

2023-01-31 ms5000001962513562 来自浙江省

我就想知道有没有被拒稿的😢

62 0

[GetPortalCommentsPageByObjectIdResponse(id=1206855, encodeId=b1701206855d2, content=上周周末汇版面费，今天发现银行那边收取15美元的手续费，我是该后期补交这个手续费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91395727558, createdName=ms8000001964189397, createdTime=Tue Mar 29 11:01:50 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147516, encodeId=c332214e51636, content=期刊名称：World Journal of Clinical Cases 影响因子：1.1 JCR分区：Q4 中科院分区：医学4区 小类：医学：内科4区 OPEN ACCESS：不清楚 出版周期：暂无数据 是否综述：否 预警等级：2023年中科院中风险预警（2021年中风险），多地黑名单预警（2023江苏省肿瘤医院中危预警、2023年度北京301医院预警、长江大学中风险预警、2022复旦大学附属华山医院不鼓励投稿预警期刊、上海市第一人民医院预警） 无视预警的单位果断投，每年收几千篇文章，属于比较好中的，速度也快，就是投稿过程比较繁琐，本人3月投的文章，6月底接收，不影响明年毕业~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e9c968577, createdName=lunasanger, createdTime=Tue Jul 11 19:16:22 CST 2023, time=2023-07-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2145331, encodeId=18f421453310f, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：病例报道;肿瘤 经验分享：竟然影响因子也有1.1分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:40:19 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1059261, encodeId=546f10592612b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：胃肠 经验分享：6月投，7月大修，9月修回。然后一定要让签署electric copyright,可惜这个electric copyright只发给了第一作者，没有发给通讯作者，然后通讯作者一直接收不到，而第一作者转发给通讯作者的电子版权协议，因为已经点击过，就没办法再点击，然后就一直耽误着，出版社说发了几次了，但始终没有接收到是怎么回事？通讯作者是hotmail的邮箱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33f45280010, createdName=1483f2a9m06(暂无昵称), createdTime=Sun Oct 10 21:39:44 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184498, encodeId=2504118449814, content=想问一下这个copyright license agreement 要五天之内提交但是并没有提交按钮还是说所有作者只要点击了accept就可以了然后和修改的文章14天之内提交上就好呀谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3085595427, createdName=ms2000000810824338, createdTime=Sat Jan 15 09:01:15 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107181, encodeId=0d7c210e181e0, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8022567422, createdName=12576f0em36暂无昵称, createdTime=Fri Dec 23 18:31:42 CST 2022, time=2022-12-23, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112349, encodeId=ea04211234942, content=我就想知道有没有被拒稿的😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Tue Jan 31 10:11:43 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2111130, encodeId=f84a211113052, content=问下各位，这个杂志让把图片编辑成PPT，可是在哪里提交呀，最后那里也没有可以提交PPT的选项呀，还是点了submit以后再提交？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14165129858, createdName=146534d9m02暂无昵称, createdTime=Sun Jan 22 11:19:47 CST 2023, time=2023-01-22, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2111261, encodeId=2d0721112616b, content=感觉今年还是预警不想发了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Mon Jan 23 23:30:07 CST 2023, time=2023-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2109480, encodeId=7433210948024, content=请问一下大家，这个copyright license agreement 所有作者都点了accept了，但邮件里说要五天之内提交，大家在哪里提交的啊？还是和修改的文章14天之内提交上就好了呀？谢谢大家！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Mon Jan 09 10:02:52 CST 2023, time=2023-01-09, status=1, ipAttribution=浙江省)]

2023-01-22 146534d9m02暂无昵称来自河北省

问下各位，这个杂志让把图片编辑成PPT，可是在哪里提交呀，最后那里也没有可以提交PPT的选项呀，还是点了submit以后再提交？

37 0

[GetPortalCommentsPageByObjectIdResponse(id=1206855, encodeId=b1701206855d2, content=上周周末汇版面费，今天发现银行那边收取15美元的手续费，我是该后期补交这个手续费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91395727558, createdName=ms8000001964189397, createdTime=Tue Mar 29 11:01:50 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147516, encodeId=c332214e51636, content=期刊名称：World Journal of Clinical Cases 影响因子：1.1 JCR分区：Q4 中科院分区：医学4区 小类：医学：内科4区 OPEN ACCESS：不清楚 出版周期：暂无数据 是否综述：否 预警等级：2023年中科院中风险预警（2021年中风险），多地黑名单预警（2023江苏省肿瘤医院中危预警、2023年度北京301医院预警、长江大学中风险预警、2022复旦大学附属华山医院不鼓励投稿预警期刊、上海市第一人民医院预警） 无视预警的单位果断投，每年收几千篇文章，属于比较好中的，速度也快，就是投稿过程比较繁琐，本人3月投的文章，6月底接收，不影响明年毕业~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e9c968577, createdName=lunasanger, createdTime=Tue Jul 11 19:16:22 CST 2023, time=2023-07-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2145331, encodeId=18f421453310f, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：病例报道;肿瘤 经验分享：竟然影响因子也有1.1分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:40:19 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1059261, encodeId=546f10592612b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：胃肠 经验分享：6月投，7月大修，9月修回。然后一定要让签署electric copyright,可惜这个electric copyright只发给了第一作者，没有发给通讯作者，然后通讯作者一直接收不到，而第一作者转发给通讯作者的电子版权协议，因为已经点击过，就没办法再点击，然后就一直耽误着，出版社说发了几次了，但始终没有接收到是怎么回事？通讯作者是hotmail的邮箱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33f45280010, createdName=1483f2a9m06(暂无昵称), createdTime=Sun Oct 10 21:39:44 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184498, encodeId=2504118449814, content=想问一下这个copyright license agreement 要五天之内提交但是并没有提交按钮还是说所有作者只要点击了accept就可以了然后和修改的文章14天之内提交上就好呀谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3085595427, createdName=ms2000000810824338, createdTime=Sat Jan 15 09:01:15 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107181, encodeId=0d7c210e181e0, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8022567422, createdName=12576f0em36暂无昵称, createdTime=Fri Dec 23 18:31:42 CST 2022, time=2022-12-23, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112349, encodeId=ea04211234942, content=我就想知道有没有被拒稿的😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Tue Jan 31 10:11:43 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2111130, encodeId=f84a211113052, content=问下各位，这个杂志让把图片编辑成PPT，可是在哪里提交呀，最后那里也没有可以提交PPT的选项呀，还是点了submit以后再提交？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14165129858, createdName=146534d9m02暂无昵称, createdTime=Sun Jan 22 11:19:47 CST 2023, time=2023-01-22, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2111261, encodeId=2d0721112616b, content=感觉今年还是预警不想发了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Mon Jan 23 23:30:07 CST 2023, time=2023-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2109480, encodeId=7433210948024, content=请问一下大家，这个copyright license agreement 所有作者都点了accept了，但邮件里说要五天之内提交，大家在哪里提交的啊？还是和修改的文章14天之内提交上就好了呀？谢谢大家！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Mon Jan 09 10:02:52 CST 2023, time=2023-01-09, status=1, ipAttribution=浙江省)]

2023-01-23 ms5000001962513562 来自浙江省

感觉今年还是预警不想发了

52 0

[GetPortalCommentsPageByObjectIdResponse(id=1206855, encodeId=b1701206855d2, content=上周周末汇版面费，今天发现银行那边收取15美元的手续费，我是该后期补交这个手续费么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91395727558, createdName=ms8000001964189397, createdTime=Tue Mar 29 11:01:50 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147516, encodeId=c332214e51636, content=期刊名称：World Journal of Clinical Cases 影响因子：1.1 JCR分区：Q4 中科院分区：医学4区 小类：医学：内科4区 OPEN ACCESS：不清楚 出版周期：暂无数据 是否综述：否 预警等级：2023年中科院中风险预警（2021年中风险），多地黑名单预警（2023江苏省肿瘤医院中危预警、2023年度北京301医院预警、长江大学中风险预警、2022复旦大学附属华山医院不鼓励投稿预警期刊、上海市第一人民医院预警） 无视预警的单位果断投，每年收几千篇文章，属于比较好中的，速度也快，就是投稿过程比较繁琐，本人3月投的文章，6月底接收，不影响明年毕业~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e9c968577, createdName=lunasanger, createdTime=Tue Jul 11 19:16:22 CST 2023, time=2023-07-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2145331, encodeId=18f421453310f, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：病例报道;肿瘤 经验分享：竟然影响因子也有1.1分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 29 05:40:19 CST 2023, time=2023-06-29, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1059261, encodeId=546f10592612b, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：胃肠 经验分享：6月投，7月大修，9月修回。然后一定要让签署electric copyright,可惜这个electric copyright只发给了第一作者，没有发给通讯作者，然后通讯作者一直接收不到，而第一作者转发给通讯作者的电子版权协议，因为已经点击过，就没办法再点击，然后就一直耽误着，出版社说发了几次了，但始终没有接收到是怎么回事？通讯作者是hotmail的邮箱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33f45280010, createdName=1483f2a9m06(暂无昵称), createdTime=Sun Oct 10 21:39:44 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184498, encodeId=2504118449814, content=想问一下这个copyright license agreement 要五天之内提交但是并没有提交按钮还是说所有作者只要点击了accept就可以了然后和修改的文章14天之内提交上就好呀谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3085595427, createdName=ms2000000810824338, createdTime=Sat Jan 15 09:01:15 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107181, encodeId=0d7c210e181e0, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8022567422, createdName=12576f0em36暂无昵称, createdTime=Fri Dec 23 18:31:42 CST 2022, time=2022-12-23, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112349, encodeId=ea04211234942, content=我就想知道有没有被拒稿的😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Tue Jan 31 10:11:43 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2111130, encodeId=f84a211113052, content=问下各位，这个杂志让把图片编辑成PPT，可是在哪里提交呀，最后那里也没有可以提交PPT的选项呀，还是点了submit以后再提交？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14165129858, createdName=146534d9m02暂无昵称, createdTime=Sun Jan 22 11:19:47 CST 2023, time=2023-01-22, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2111261, encodeId=2d0721112616b, content=感觉今年还是预警不想发了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Mon Jan 23 23:30:07 CST 2023, time=2023-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2109480, encodeId=7433210948024, content=请问一下大家，这个copyright license agreement 所有作者都点了accept了，但邮件里说要五天之内提交，大家在哪里提交的啊？还是和修改的文章14天之内提交上就好了呀？谢谢大家！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Mon Jan 09 10:02:52 CST 2023, time=2023-01-09, status=1, ipAttribution=浙江省)]

2023-01-09 ms5000001962513562 来自浙江省

请问一下大家，这个copyright license agreement 所有作者都点了accept了，但邮件里说要五天之内提交，大家在哪里提交的啊？还是和修改的文章14天之内提交上就好了呀？谢谢大家！！

4 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务